And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Despite the long weekend coming up on this side of the pond, our agenda is rather modest. We plan to spend time with Mrs. Pharmalot, hang with a short person or two, and look in on the Pharmalot ancestors. And maybe catch up on some reading. And what about you? This is a fine time to take in a moving picture. You could prepare your taxes — remember, someone has to pay for that White House budget. Or you could make time for someone special. This is the time of year to acknowledge that sweet person in your life. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you on Tuesday.

Americans with private employer health insurance spent nearly 26% more on prescription drugs from 2014 to 2018, STAT writes, citing a new analysis. At the same time, the average price of a medicine purchased by each employee rose by almost 21% and their usage rose more than 4% during that time period. Moreover, the rate at which prescription drug spending rose also outpaced the increased cost of other medical services, such as doctor visits and hospital admissions, during those five years.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy